abstract |
The present disclosure provides novel anhydrous crystalline forms 1 and 4 of 4'-ethynyl-2-fluoro-2'-deoxyadenosine, and pharmaceutical compositions thereof, each of which inhibits HIV reverse transcriptase, It may be useful in treating or preventing and/or treating, preventing and/or delaying the onset or progression of AIDS or ARC. |